- Visibility 757 Views
- Downloads 1.9k Downloads
- Permissions
- DOI 10.18231/j.ijogr.v.12.i.3.6
-
CrossMark
Methylergometrine role in clinical practice
- Author Details:
-
Mayank Dhore *
-
Atul Munshi
-
Milind Gaitonde
-
Ninad Chaudhary
-
Monil Gala
-
Snehal Muchhala
-
Bhavesh Kotak
Mayank Dhore *
Postpartum haemorrhage (PPH) is a major cause of morbidity and mortality, with uterine atony accounting for 70-80% of all haemorrhages. According to the experts, the incidence of PPH ranges from 3% to 5%. The most common causes include uterine atony, laceration, accidental haemorrhage, and abnormal placentation. Factors that increase the risk of PPH include advanced age, assisted reproduction technology, and advanced age-associated co-morbidities. Even though guidelines recommend oxytocin as the first option, experts consider methylergometrine to be the ideal uterotonic in clinical practice in case of either normal vaginal or C-section delivery. The current consensus article aims to provide a collation of evidence-based literature and clinical insights from the experts on epidemiology, risk factors, and predictors of PPH. The article also provides a consensus on the role of methylergometrine (methylergonovine) in the management of PPH. Overall, methylergometrine alone or in combination with oxytocin is among the first-line drugs for the management of PPH with a favourable safety profile and cost-effectiveness.
References
- Maternal mortality. World Health Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/maternal- mortality#:~:text=Every%20day%20in%202020%2C%20almost,d ropped%20by%20about%2034%25%20worldwide. Accessed March 16, 2023.
- Maternal mortality. UNICEF. Available from: https://data.unicef.org/topic/maternal-health/maternal-mortality/. Accessed March 16, 2023.
- Meh C, Sharma A, Ram U, Fadel S, Correa N, Snelgrove JW, et al. Trends in maternal mortality in India over two decades in nationally representative surveys. BJOG. 2022;129(4):550–61.
- Amanuel T, Dache A, Dona A. Postpartum hemorrhage and its associated factors among women who gave birth at Yirgalem General Hospital, Sidama Regional State, Ethiopia. Health Serv Res Manag Epidemiol. 2021;8:23333928211062777.
- Jigyasa S, Agrawal S, Pandey U, Sachan S, Rajan M, Singh TB, et al. Implementation of postpartum hemorrhage emergency care using a bundle approach at a tertiary care hospital in North India. Cureus. 2022;14(7):e26819.
- Wormer KC, Jamil RT, Bryant SB. Acute postpartum hemorrhage. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. [Updated 2022 Oct 25]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499988/.
- Feduniw S, Warzecha D, Szymusik I, Wielgos M. Epidemiology, prevention and management of early postpartum hemorrhage - a systematic review. Ginekol Pol. 2020;91(1):38–44.
- Chainarong N, Deevongkij K, Petpichetchian C. Secondary postpartum hemorrhage: Incidence, etiologies, and clinical courses in the setting of a high cesarean delivery rate. PLoS One. 2022;17(3): e0264583.
- Pubu ZM, Bianba ZM, Yang G, CyRen L, Pubu D, Suo Lang K, et al. Factors affecting the risk of postpartum hemorrhage in pregnant women in Tibet health facilities. Med Sci Monit. 2021;27:e928568.
- Evensen A, Anderson JM, Fontaine P. Postpartum hemorrhage: prevention and treatment. Am Fam Physician. 2017;95(7):442–9.
- Correa-de-Araujo R, Yoon SSS. Clinical outcomes in high-risk pregnancies due to advanced maternal age. J Womens Health (Larchmt). 2021;30(2):160–7.
- Fukami T, Koga H, Goto M, Ando M, Matsuoka S, Tohyama A, et al. Incidence and risk factors for postpartum hemorrhage among transvaginal deliveries at a tertiary perinatal medical facility in Japan. PLoS One. 2019;14(1):e0208873.
- Yamamura A, Okuda A, Abe A, Kashihara Y, Kozono Y, Sekiyama K, et al. The impact of assisted reproductive technology on the risk of postpartum hemorrhage: difference by the mode of delivery and embryo transfer. J Obstet Gynaecol Res. 2023;49(4):1167–72.
- Maher GM, McKernan J, O'Byrne L, Corcoran P, Greene RA, Khashan AS, et al. Predicting risk of postpartum haemorrhage during the intrapartum period in a general obstetric population. Eur J Obstet Gynecol Reprod Biol. 2022;276:168–73.
- Chen Y, Xu T. Prediction for postpartum hemorrhage of placenta previa patients through MRI using self-adaptive edge detection algorithm. Contrast Media Mol Imaging. 2021;2021:8343002.
- Mousa HA, Blum J, Abou El Senoun G,etal. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2014;2014(2):CD003249.
- Fox R, Aitken G, Mooney SS. Management of secondary postpartum haemorrhage: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2023;282:116-123.
- Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;4(4):CD011689.
- WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization. Available from: https://apps.who.int/iris/bitstream/handle/10665/75411/978924154 8502_eng.pdf. Accessed March 15, 2023.
- Vogel JP, Williams M, Gallos I, Althabe F, Oladapo OT. WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one? BMJ Glob Health. 2019;4(2):e001466.
- Escobar MF, Nassar AH, Theron G, Barnea ER, Nicholson W, Ramasauskaite D, et al. FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynaecol Obstet. 2022;157(Suppl 1):3–50.
- PPH prevention and management: updated PPH guidelines. Federation of Obstetric and Gynaecological Societies of India (FOGSI). Available from: https://www.fogsi.org/wp- content/uploads/tog/pph-prevention-and-management-updated- sept-2022.pdf. Accessed March 15, 2023.
- Postpartum haemorrhage. https://www.fogsi.org/wp- content/uploads/fogsi- focus/prediction_prevention_PPH_focus_01.pdf
- Singangutti R. Intramuscular methylergometrine versus per- rectal misoprostol for prevention of atonic post-partum haemorrhage Int J Reprod Contracept Obstet Gynecol. 2018;7(4):1490–3.
- Methylergometrine. U.S. Food and Drug Administration. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/00603 5s078lbl.pdf. Accessed March 15, 2023.
- Boopathi A, Nayak SR, Rao A, Rao B. Oxytocin versus methylergometrine in the active management of third stage of labour. Open J Obstet Gynecol. 2014;4(11):666–71.
- Anvaripour A, Shahryari H, Ahmadi S, Ghasemi S, Mirzaei K. Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia. Arch Gynecol Obstet. 2013;287(5):979–83. Dhore et al. / Indian Journal of Obstetrics and Gynecology Research 2025;12(3):392–399 399
- Masse N, Wong C, Dexter F. A randomized controlled trial to assess prophylactic methylergonovine in patients undergoing an intrapartum cesarean section. Am J Obstet Gynecol . 2022;226(1):S34.
- Amant F, Spitz B, Timmerman D, Corremans A, Van Assche FA. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial. Br J Obstet Gynaecol. 1999;106(10):1066–70.
- Dweck MF, Lynch CM, Spellacy WN. Use of methylergometrine for the prevention of postoperative endometritis in non-elective cesarean section patients. Infect Dis Obstet Gynecol. 2000;8(3- 4):151–4.
- Gilad O, Merlob P, Stahl B, Averbuch N, Klinger G. Outcome of breastfed infants following post-partum methylergonovine treatment. J Matern Fetal Neonatal Med. 2017;30(13):1569–73.
- Vuilleumier PH, Surbek D. Anesthesiologic management of major obstetrical hemorrhage. Trends Anaesth Crit Care. 2015;5(6):167–
- Sahu L, Thakur P, Gandhi G, Agarwal K. A randomized comparative study to compare the efficacy of oxytocin, misoprostol, 15- methyl pgf2α and methyl ergometrine in active management of third stage of labor. Eur J Biomed Pharm Sci. 2016;3(5):273–8.
- Widmer M, Piaggio G, Nguyen TMH, Osoti A, Owa OO, Misra S, et al. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med. 2018;379(8):743–52.
- Gizzo S, Patrelli TS, Gangi SD, Carrozzini M, Saccardi C, Zambon A, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci. 2013;20(9):1011–9.
- Myers SP, Kutcher ME, Rosengart MR, Sperry JL, Peitzman AB, Brown JB, et al. Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg. 2019;86(1):20–7.